Biometrics are integral to personalized medicine, where treatment is tailored to the individual's specific genetic profile and the characteristics of their cancer. By analyzing biomarkers, physicians can determine the most effective therapies, predict the response to treatment, and monitor the effectiveness of ongoing treatments. For example, the presence of certain genetic mutations can indicate whether a patient will respond to targeted therapies like PARP inhibitors or immunotherapy.
